Nephrology

Pediatric Oncology

Questions discussed in this category

For patients with suspected complement-mediated TMA, are there specific clinical or laboratory parameters that can help guide the decision for starting empirical treatment (e.g., eculizumab) while awaiting the results of complement testing?

1 Answer available

How do you manage patients blood pressures while on anti-angiogenic TKIs?

Do you insist on ambulatory/home blood pressures to rule in/out white coat hypertension? Does your practice have a system to log patients' BPs to supp...

1 Answer available

Do you recommend preloading with IV magnesium to decrease the risk of cisplatin nephrotoxicity?

3 Answers available

How do you dose apixaban in patients with CrCl <30 mL/minute?

1 Answer available

What is your strategy for managing immunosuppression in patients with a kidney transplant who develop metastatic cancer?

3 Answers available

Do you hold IV iron in the setting of active infection?

1 Answer available

Papers discussed in this category

Circulation, 2022 Nov 06

A Randomized Controlled Trial Comparing Apixaban With the Vitamin K Antagonist Phenprocoumon in Patients on Chronic Hemodialysis: The AXADIA-AFNET 8 Study.

Circulation, 2022 Nov 06

Apixaban for Patients With Atrial Fibrillation on Hemodialysis: A Multicenter Randomized Controlled Trial.

Transplantation reviews (Orlando, Fla.), 2021 Jun 24

Management of the kidney transplant patient with Cancer: Report from a Multidisciplinary Consensus Conference.

Nephrology

Pediatric Oncology

Questions discussed in this category

Papers discussed in this category

Related Topics in Nephrology